MAPT and Alzheimer disease: Furthermore, the brains of individuals with AD have been found to have significant upregulation of phosphorylated C‐terminal fragments of APP (APP‐CTFs) at Thr668, as well as elevated levels of GSK‐3β and Tau phosphorylation in the brain.242